Powder: -20°C for 3 years
In solvent: -80°C for 2 years
GDP366, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. a dual inhibitor of Survivin and Op18.
Description | GDP366, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. a dual inhibitor of survivin and Op18. |
In vitro | GDP366 induces polyploidy in multiple types of cancer cell lines. GDP366 decreass both the mRNA and protein levels of survivin and Op18. This inhibitory effect is not dependent on the status of p53 and p21 although GDP366 potently increases p53 and p21 levels. GDP366 significantly inhibits the growth of tumor cells in vitro and in vivo (nude mouse model) without rapid induction of apoptosis[1]. |
Molecular Weight | 375.45 |
Formula | C20H17N5OS |
CAS No. | 501698-03-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 60 mg/mL (159.81 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GDP366 501698-03-9 Apoptosis Survivin GDP-366 GDP 366 inhibit Inhibitor inhibitor